Stanford University

Recent Events

News & Analysis

company and stanford university - All News and Analysis

• New Case Study by Stanford University Graduate School of Business Details Successful ClearOrbit Supply Chain Collaboration

  - 2007-02-28

  Company's Partnership with World Wide Technology Connects More Than 1,200 Suppliers for Major Automotive OEM's Automated Materials Replenishment

  Tags: collaboration, Company, Stanford University

• Raptor Pharmaceuticals Corp. Announces Research Collaboration With Stanford University on the Use of NeuroTrans(TM) to Deliver Therapeutics Across the Blood-Brain Barrier.

  - 2006-08-01

  NOVATO, California, August 1 /PRNewswire/ -- Raptor Pharmaceuticals Corp. (the "Company") (OTC Bulletin Board: RPTP.OB), today announced that its wholly-owned subsidiary, Raptor Pharmaceutical Inc., has signed a research collaboration agreement with Dr. William Mobley, Professor of Neurology and Neurological Sciences at the Stanford...

  Tags: Collaboration, Company, Dr., Groupware, Raptor Pharmaceuticals Corp., SEC, SOFTWARE, Stanford, Stanford University

• Threshold Pharmaceuticals Appoints William A. Halter and George G. C. Parker to Board of Directors

  - 2004-10-13

  SOUTH SAN FRANCISCO, Calif. -- Threshold Pharmaceuticals, Inc. today announced the addition of William A. Halter and George G. C. Parker, Ph.D. to its board of directors. Mr. Halter has over 20 years of leadership experience in the public and private sectors. Nominated by the President and confirmed by...

  Tags: board, Company, FINANCE, Stanford, Stanford University

• Ameron Announces Appointments to Board of Directors

  - 2002-11-27

  Business Editors PASADENA, Calif.--BUSINESS WIRE--Nov. 27, 2002 Ameron International Corporation (NYSE: AMN) today announced three appointments to the Company's board of directors. Joining the Ameron board of directors are: David Davenport, Thomas L. Lee and Dennis C. Poulsen. David Davenport is a Research Fellow at the Hoover...

  Tags: board, California, Company, Davenport Co., NYSE Euronext, Stanford University

• Usertech/Canterbury Goes Back to School at Stanford University

  - 2002-10-03

  Business Editors/Hi-Tech Writers MEDFORD, N.J.--BUSINESS WIRE--Oct. 3, 2002 Canterbury Consulting Group, Inc. (NASDAQ:CITI) announced today that Usertech/Canterbury Corp., a wholly owned subsidiary of Canterbury Consulting Group specializing in custom learning solutions, is working on the training component of Stanford University's PeopleSoft HRMS implementation. As Stanford moves from a...

  Tags: Company, Stanford University, training

• Data On Endovasc's Licensed Angiogenic Agent, Nicotine Receptor Agonist is Published in Nature Medicine

  - 2001-07-09

  Business Editors/Health & Medical Writers BIOWIRE2K MONTGOMERY, Texas--BW HealthWire--July 9, 2001 Stanford University Researchers Discover Nicotine Promotes Growth of New Blood Vessels Endovasc Ltd. Inc. (OTCBB:ENDV) today announced the publication of data by Stanford University showing nicotine is capable of affecting the formation of new...

  Tags: Company, Dr., researcher, Stanford, Stanford University

• Peregrine Pharmaceuticals Announces the Treatment of the First Patient in the Stanford University Cotara Clinical Trial

  - 2000-11-30

  Business Editors/Health & Medical Writers TUSTIN, Calif.--BUSINESS WIRE--Nov. 30, 2000 Colorectal Cancer Treated with CotaraTM Administered Intravenously Peregrine Pharmaceuticals Inc. (Nasdaq:PPHM), today announced that the first patient has been enrolled and treated in the new Phase I clinical study for colorectal cancer being conducted at Stanford...

  Tags: Company, patient, Stanford University

• ICOS Receives Exclusive License From Stanford

  - 2000-11-13

  Business/Health Editors BOTHELL, Wash.--BUSINESS WIRE--Nov. 13, 2000 ICOS Corporation (Nasdaq:ICOS) today announced an exclusive license agreement with Stanford University for polyphosphate kinase technology that was developed in the laboratory of Arthur Kornberg, M.D., Nobel laureate and Professor Emeritus, Department of Biochemistry at Stanford University. Polyphosphate kinase PPK...

  Tags: antibiotics, bacteria, cell, Company, ICOS Corp., Stanford University

• COR Therapeutics, Inc. Appoints James N. Topper, M.D., Ph.D., Vice President, Biology

  - 1999-09-22

  SOUTH SAN FRANCISCO, Calif.--BW HealthWire--Sept. 22, 1999-- COR Therapeutics, Inc. (Nasdaq:CORR) announced today that James N. Topper, M.D., Ph.D., has joined the Company as Vice President, Biology. In this newly created position, Dr. Topper will have overall responsibility for the biological research responsibilities at COR and will report directly...

  Tags: biology, Company, Dr., M.D., Stanford University

• Donald Kennedy Joins Board At CytoTherapeutics; Former FDA Commissioner and President Emeritus of Stanford University

  - 1999-07-23

  LINCOLN, R.I.--BUSINESS WIRE--July 23, 1999-- CytoTherapeutics, Inc. (Nasdaq:CTII) today announced the election of Donald Kennedy, Ph.D., to its Board of Directors. Since 1960, Dr. Kennedy has held a number of academic research, advisory and public policy positions related to health and the environment. Dr. Kennedy currently co-directs the Center...

  Tags: board, chairman, Company, Dr., FDA, M.D., Stanford University, stem-cell